Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Port

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
International Journal of Surgery (London, England)|April 13, 2023
Volume outcome relationship in postesophagectomy leak: a systematic review and meta-analysisMohamed Rahouma, Massimo Baudo, Nathan Mynard, et al.
Cancer Research|January 28, 2012
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transitionDingcheng Gao, Natasha Joshi, Hyejin Choi, et al.
Neuroimage. Clinical|August 6, 2024
Diffusion tensor analysis of white matter tracts is prognostic of persisting post-concussion symptoms in collegiate athletesGiulia Bertò, Lauren T Rooks, Steven P Broglio, et al.
The Lancet. Oncology|May 20, 2021
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trialNasser K Altorki, Timothy E McGraw, Alain C Borczuk, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Nature Communications|January 3, 2024
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trialNasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Nature Communications|December 19, 2023
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trialNasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Nature Methods|May 7, 2024
Author Correction: brainlife.io: a decentralized and open-source cloud platform to support neuroscience researchSoichi Hayashi, Bradley A Caron, Anibal Sólon Heinsfeld, et al.
Nature Methods|April 11, 2024
brainlife.io: a decentralized and open-source cloud platform to support neuroscience researchSoichi Hayashi, Bradley A Caron, Anibal Sólon Heinsfeld, et al.
Arxiv|June 19, 2023
<i>brainlife.io</i>: A decentralized and open source cloud platform to support neuroscience researchSoichi Hayashi, Bradley A Caron, Anibal Sólon Heinsfeld, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
International Journal of Surgery (London, England)|April 13, 2023
Volume outcome relationship in postesophagectomy leak: a systematic review and meta-analysisMohamed Rahouma, Massimo Baudo, Nathan Mynard, et al.
Cancer Research|January 28, 2012
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transitionDingcheng Gao, Natasha Joshi, Hyejin Choi, et al.
Neuroimage. Clinical|August 6, 2024
Diffusion tensor analysis of white matter tracts is prognostic of persisting post-concussion symptoms in collegiate athletesGiulia Bertò, Lauren T Rooks, Steven P Broglio, et al.
The Lancet. Oncology|May 20, 2021
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trialNasser K Altorki, Timothy E McGraw, Alain C Borczuk, et al.
Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.
Nature Communications|January 3, 2024
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trialNasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Nature Communications|December 19, 2023
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trialNasser K Altorki, Zachary H Walsh, Johannes C Melms, et al.
Nature Methods|May 7, 2024
Author Correction: brainlife.io: a decentralized and open-source cloud platform to support neuroscience researchSoichi Hayashi, Bradley A Caron, Anibal Sólon Heinsfeld, et al.
Nature Methods|April 11, 2024
brainlife.io: a decentralized and open-source cloud platform to support neuroscience researchSoichi Hayashi, Bradley A Caron, Anibal Sólon Heinsfeld, et al.
Arxiv|June 19, 2023
<i>brainlife.io</i>: A decentralized and open source cloud platform to support neuroscience researchSoichi Hayashi, Bradley A Caron, Anibal Sólon Heinsfeld, et al.
Pageof 20